Accueil>>Signaling Pathways>> Immunology/Inflammation>> nNOS>>α-Guanidinoglutaric Acid

α-Guanidinoglutaric Acid (Synonyms: GGA)

Catalog No.GC11323

linear mixed-type inhibitor of nNOS

Products are for research use only. Not for human use. We do not sell to patients.

α-Guanidinoglutaric Acid Chemical Structure

Cas No.: 73477-53-9

Taille Prix Stock Qté
5mg
38,00 $US
En stock
10mg
70,00 $US
En stock
50mg
290,00 $US
En stock
100mg
500,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of α-Guanidinoglutaric Acid

α-Guanidinoglutaric Acid is a novel nitric oxide synthase inhibitor with Ki value of 2.69 μM [1].

In the brain, nitric oxide (NO), which is synthesized from L-arginine (Arg) by NO synthase (NOS), acts as both an intra- and an intercellular second messenger, and it may suppress convulsions [1].

α-Guanidinoglutaric Acid (GGA) is a novel nitric oxide synthase inhibitor. GGA was increased in the cobalt-induced epileptic focus tissue in the cerebral cortex of cats [2]. GGA is an endogenous, potent, and non-guanidino nitrogen-substituted NOS inhibitor and that inhibition of nitric oxide biosynthesis may be involved in GGA-induced convulsions. In the cobalt-induced epileptic focus, GGA might inhibit NO production. GGA is a useful tool for the study of the enzyme-substrate relationship of NOS [1].

In rats, GGA injected in the cerebroventricle caused sporadic spike discharges with a latency of several minutes. When Arg was supplemented with GGA, no sporadic spike discharges were observed. These results indicated that Arg elevated the threshold of GGA-induced seizures. The initiation of the seizures induced by GGA was associated with a decrease in the 5-hydroxytryptamine level [1].

References:
[1].  Yokoi I, Kabuto H, Habu H, Mori A. alpha-Guanidinoglutaric acid, an endogenous convulsant, as a novel nitric oxide synthase inhibitor. J Neurochem. 1994 Oct;63(4):1565-7.
[2].  Mori A, Akagi M, Katayama Y, et al. alpha-Guanidinoglutaric acid in cobalt-induced epileptogenic cerebral cortex of cats. J Neurochem. 1980 Sep;35(3):603-5.

Chemical Properties of α-Guanidinoglutaric Acid

Cas No. 73477-53-9 SDF
Synonymes GGA
Chemical Name N-(aminoiminomethyl)-L-glutamic acid
Canonical SMILES NC(=N)N[C@@H](CCC(=O)O)C(=O)O
Formula C6H11N3O4 M.Wt 189.2
Solubility ≤50mg/ml in aqueous solutions Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of α-Guanidinoglutaric Acid

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 5.2854 mL 26.4271 mL 52.8541 mL
5 mM 1.0571 mL 5.2854 mL 10.5708 mL
10 mM 0.5285 mL 2.6427 mL 5.2854 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of α-Guanidinoglutaric Acid

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Avis

Review for α-Guanidinoglutaric Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for α-Guanidinoglutaric Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.